Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers

Fig. 1

The research overflow, essential roles, and expression of CEP55 in cancers. Panel A: The research overflow of this study. Panel B: Identification of essential roles of CEP55 for multiple cancers. Panel C: The differential expression of CEP55 mRNA between cancers and controls; p-value was based on the Wilcoxon rank-sum test with a false discovery rate. Panel D: The differential levels of CEP55 protein between cancers and controls. ns/NSp > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001

Back to article page